| Literature DB >> 35316562 |
Yoko Nagamori1,2, Marisa A Litherland1, Nicole R Koons1, Anna R Linthicum2, Akhilesh Ramachandran1,2.
Abstract
BACKGROUND: As a population of non-migratory Canada geese (Branta canadensis) has been growing in residential and recreational areas, public concerns on potential acquisition of zoonotic pathogens from Canada geese and their faecal deposits have been increasing.Entities:
Keywords: Campylobacter; Cryptosporidium; Giardia; Salmonella; antimicrobial resistance
Mesh:
Substances:
Year: 2022 PMID: 35316562 PMCID: PMC9297773 DOI: 10.1002/vms3.791
Source DB: PubMed Journal: Vet Med Sci ISSN: 2053-1095
Prevalence of intestinal parasites identified in faecal samples of Canada geese inhabited in Stillwater, Payne county
| Sampling locations in Stillwater, Payne county (total number of samples) | Total ( | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L‐1 ( | L‐2 ( | L‐3 ( | L‐4 ( | L‐5 ( | ||||||||
| Parasites | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) |
| Ascarid eggs | 8 | 28.6 (14.2–48.2) | 1 | 1.7 (0.9–58.9) | 10 | 43.5 (24.7–64.0) | 6 | 33.3 (15.6–58.6) | 13 | 61.9 (40.3–80.3) | 38 | 39.6 (30.1–50.0) |
|
| 0 | 0.0 (0.0–11.9) | 0 | 0.0 (0.0–41.1) | 0 | 0.0 (0.0–14.5) | 0 | 0.0 (0.0–18.5) | 0 | 0.0 (0.0–15.9) | 0 | 0.0 (0.0–3.91) |
| Cestode eggs | 0 | 0.0 (0.0–11.9) | 0 | 0.0 (0.0–41.1) | 1 | 4.3 (0.2–21.3) | 0 | 0.0 (0.0–18.5) | 0 | 0.0 (0.0–15.9) | 1 | 1.0 (0.06–5.6) |
|
| 0 | 0.0 (0.0–11.9) | 0 | 0.0 (0.0–41.1) | 0 | 0.0 (0.0–14.5) | 0 | 0.0 (0.0–18.5) | 0 | 0.0 (0.0–15.9) | 0 | 0.0 (0.0–3.91) |
|
| 0 | 0.0 (0.0–11.9) | 0 | 0.0 (0.0–41.1) | 0 | 0.0 (0.0–14.5) | 0 | 0.0 (0.0–18.5) | 0 | 0.0 (0.0–15.9) | 0 | 0.0 (0.0–3.91) |
| Coccidian oocysts | 16 | 57.1 (38.1–74.2) | 6 | 100.0 (58.9–100.0) | 18 | 78.2 (56.7–91.0) | 8 | 44.4 (23.7–67.0) | 21 | 100.0 (84.1–100.0) | 69 | 71.9 (62.0–80.3) |
| Schistosome eggs | 0 | 0.0 (0.0–11.9) | 0 | 0.0 (0.0–41.1) | 0 | 0.0 (0.0–14.5) | 1 | 5.6 (0.3–27.1) | 0 | 0.0 (0.0–15.9) | 1 | 0.0 (0.0–3.91) |
| Strongylid eggs | 6 | 21.4 (9.8–40.9) | 1 | 1.7 (0.9–58.9) | 3 | 13.0 (3.7–32.4) | 2 | 11.1 (2.0–33.0) | 7 | 33.3 (15.9–55.1) | 19 | 19.8 (12.9–29.1) |
|
| 0 | 0.0 (0.0–11.9) | 0 | 0.0 (0.0–41.1) | 1 | 4.3 (0.2–21.3) | 0 | 0.0 (0.0–18.5) | 0 | 0.0 (0.0–15.9) | 1 | 0.0 (0.0–3.91) |
| Total parasites detected | 30 | n/a | 8 | n/a | 33 | n/a | 17 | n/a | 41 | n/a | 129 | n/a |
Note: A total of 129 parasites with six different parasite groups/genera were detected in 96 faecal samples.
Prevalence of intestinal parasites identified in faecal samples of Canada geese inhabited in Edmond, Norman and Oklahoma City, Oklahoma county
| Sampling locations in Edmond, Norman and Oklahoma City, Oklahoma county (total number of samples) | Total ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| L‐6 ( | L‐7 ( | L‐8 ( | L‐9 ( | |||||||
| Parasites | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) |
| Ascarid eggs | 16 | 41.0 (26.7–57.8) | 12 | 50.0 (31.0–69.0) | 3 | 75.0 (24.9–98.7) | 6 | 54.5 (26.5–80.0) | 37 | 47.4 (36.5–58.8) |
|
| 0 | 0.0 (0.0–8.6) | 0 | 0.0 (0.0–13.9) | 0 | 0.0 (0.0–52.7) | 3 | 27.3 (7.9–59.6) | 3 | 3.8 (1.1–10.7) |
| Cestode eggs | 1 | 2.6 (0.1–13.6) | 0 | 0.0 (0.0–13.9) | 0 | 0.0 (0.0–52.7) | 0 | 0.0 (0.0–26.5) | 1 | 1.3 (0.07–6.83) |
|
| 0 | 0.0 (0.0–8.6) | 0 | 0.0 (0.0–13.9) | 0 | 0.0 (0.0–52.7) | 0 | 0.0 (0.0–26.5) | 0 | 0.0 (0.0–4.8) |
|
| 0 | 0.0 (0.0–11.9) | 0 | 0.0 (0.0–13.9) | 0 | 0.0 (0.0–52.7) | 0 | 0.0 (0.0–26.5) | 0 | 0.0 (0.0–4.8) |
| Coccidian oocysts | 35 | 89.7 (75.9–96.4) | 12 | 50.0 (31.0–69.0) | 4 | 100.0 (47.3–100.0) | 7 | 63.6 (33.3–86.5) | 58 | 73.1 (62.2–82.2) |
| Schistosome eggs | 0 | 0.0 0.0–8.6) | 0 | 0.0 (0.0–13.9) | 0 | 0.0 (0.0–52.7) | 0 | 0.0 (0.0–26.5) | 0 | 0.0 (0.0–4.8) |
| Strongylid eggs | 4 | 10.3 (3.6–24.1) | 3 | 12.5 (3.5–31.0) | 0 | 0.0 (0.0–52.7) | 3 | 27.3 (7.9–59.6) | 10 | 12.8 (6.8–22.3) |
|
| 1 | 2.6 (0.1–13.6) | 0 | 0.0 (0.0–13.9) | 0 | 0.0 (0.0–52.7) | 1 | 9.0 (0.5–40.4) | 2 | 2.6 (0.5–8.8) |
| Total parasites detected | 57 | n/a | 27 | n/a | 7 | n/a | 20 | n/a | 111 | n/a |
Note: A total of 111 parasites with seven different parasite groups/genera were detected in 78 faecal samples.
Of 35 coccidia samples, one sample collected from the L‐7 contained Isospora spp. oocysts.
Prevalence of intestinal parasites identified in faecal samples of Canada geese inhabited in Broken Arrow, Tulsa county
| Sampling locations in Broken Arrow, Tulsa county (total number of samples) | Total ( | |||||
|---|---|---|---|---|---|---|
| L‐10 ( | L‐11 ( | |||||
| Parasites | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) | Positive number | Prevalence % (95% CI) |
| Ascarid eggs | 3 | 15.8 (4.4–39.2) | 5 | 45.5 (20.0–73.5) | 8 | 26.7 (13.1–44.9) |
|
| 0 | 0.0 (0.0–17.6) | 0 | 0.0 (0.0–26.5) | 0 | 0.0 (0.0–11.2) |
| Cestode eggs | 0 | 0.0 (0.0–17.6) | 0 | 0.0 (0.0–26.5) | 0 | 0.0 (0.0–11.2) |
|
| 0 | 0.0 (0.0–17.6) | 0 | 0.0 (0.0–26.5) | 0 | 0.0 (0.0–11.2) |
|
| 0 | 0.0 (0.0–17.6) | 0 | 0.0 (0.0–26.5) | 0 | 0.0 (0.0–11.2) |
| Coccidian oocysts | 16 | 84.2 (60.8–95.6) | 10 | 90.0 (59.6–99.5) | 26 | 86.7 (70.2–95.3) |
| Schistosome eggs | 0 | 0.0 (0.0–17.6) | 0 | 0.0 (0.0–26.5) | 0 | 0.0 (0.0–11.2) |
| Strongylid eggs | 7 | 36.8 (17.6–60.8) | 2 | 18.2 (3.3–50.0) | 9 | 30.0 (16.3–48.3) |
|
| 0 | 0.0 (0.0–17.6) | 0 | 0.0 (0.0–26.5) | 0 | 0.0 (0.0–11.2) |
| Total parasites detected | 26 | n/a | 17 | n/a | 43 | n/a |
Note: A total of 43 parasites with three different parasite groups/genera were detected in 30 faecal samples.
Intestinal bacteria identified in pooled faecal samples of Canada geese inhabited in North‐Central Oklahoma
| Sampling locations (total number of pooled samples) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stillwater, Payne county ( | Edmond and Oklahoma City, Oklahoma county ( | Broken Arrow, Tulsa county ( | ||||||||||
| Bacteria | Family | L‐1 ( | L‐2 ( | L‐3 ( | L‐4 ( | L‐5 ( | L‐6 ( | L‐7 ( | L‐8 ( | L‐9 ( | L‐10 ( | L‐11 ( |
|
| Aeromonadaceae | X | X | X | X | |||||||
|
| Bacillaceae | X | X | X | X | X | X | X | X | X | X | X |
|
| X | |||||||||||
|
| X | |||||||||||
|
| X | X | ||||||||||
|
| Clostridiaceae | X | X | X | X | |||||||
|
| Comamonadaceae | X | ||||||||||
|
| Enterobacteriaceae | X | X | X | X | X | ||||||
|
| X | X | X | X | X | X | X | X | X | X | X | |
|
| X | X | X | X | X | |||||||
|
| X | X | ||||||||||
|
| X | |||||||||||
|
| X | X | ||||||||||
|
| X | X | X | X | X | |||||||
|
| X | |||||||||||
|
| X | X | X | X | ||||||||
|
| X | |||||||||||
|
| X | |||||||||||
|
| X | X | ||||||||||
|
| Enterococcaceae | X | X | X | X | X | X | X | ||||
|
| Microbacteriaceae | X | ||||||||||
|
| Micrococcaceae | X | ||||||||||
|
| Pseudomonadaceae | X | X | X | ||||||||
|
| Saccharomycetaceae | X | ||||||||||
| alpha | Streptococcaceae | X | ||||||||||
Note: An ‘X’ demonstrates that the bacteria listed were cultured and identified from the corresponding location.
Antimicrobial susceptibilities of 32 E. coli isolates recovered from the faecal samples of Canada geese residing in 3 counties of North‐Central Oklahoma
|
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Susceptible 5% CI |
Intermediate 5% CI |
Resistant 5% CI |
Susceptible 95% CI |
Intermediate 95% CI |
Resistant 95% CI |
Susceptible 95% CI |
Intermediate 95% CI |
Resistant 95% CI |
Susceptible 95% CI |
Intermediate 95% CI |
Resistant 95% CI | |
| Amikacin |
11 (100.0) 73.6–100.0 |
0 (0.0) 0.0–26.5 |
0 (0.0) 0.0–26.5 |
15 (100.0) 77.8–100.0 |
0 (0.0) 0.0–22.2 |
0 (0.0) 0.0–22.2 |
5 (83.3) 41.1–99.1 |
1 (16.7) 0.86–58.9 |
0 (0.0) 0.0–41.1 |
31 (96.9) 83.4–99.8 |
1 (3.1) 0.17–16.6 |
0 (0.0) 0.0–10.5 |
| Amoxicillin‐clavulanate |
4 (36.4) 13.5–66.7 |
6 (54.6) 26.5–80.0 |
1 (9.1) 0.47–40.4 |
10 (66.7) 39.7–85.8 |
5 (33.3) 14.2–60.3 |
0 (0.0) 0.0–22.2 |
4 (66.7) 27.1–93.7 |
2 (33.3) 6.3–72.9 |
0 (0.0) 0.0–41.1 |
18 (56.3) 39.0–72.2 |
13 (40.6) 24.7–58.0 |
1 (3.1) 0.17–16.6 |
| Ampicillin |
8 (72.7) 40.5–92.1 |
1 (9.1) 0.47–40.4 |
2 (18.2) 33.4–50.0 |
10 (66.7) 39.7–85.8 |
5 (33.3) 14.2–60.3 |
0 (0.0) 0.0–22.2 |
6 (100.0) 58.9–100.0 |
0 (0.0) 0.0–41.1 |
0 (0.0) 0.0–41.1 |
24 (75.0) 57.7–87.8 |
6 (18.8) 8.5–35.8 |
2 (6.3) 1.1–20.0 |
| Azithromycin |
5 (45.5) 20.0–73.5 |
0 (0.0) 0.0–26.5 |
6 (54.6) 26.5–80.0 |
9 (60.0) 33.2–80.9 |
0 (0.0) 0.0–22.2 |
6 (40.0) 19.1–66.8 |
2 (33.3) 6.3–72.9 |
0 (0.0) 0.0–41.1 |
4 (66.7) 27.1–93.7 |
16 (50.0) 32.6–67.4 |
0 (0.0) 0.0–10.5 |
16 (50.0) 32.6–67.4 |
| Cefoxitin |
10 (90.9) 59.6–99.5 |
1 (9.1) 0.47–40.4 |
0 (0.0) 0.0–26.5 |
15 (100.0) 77.8–100.0 |
0 (0.0) 0.0–22.2 |
0 (0.0) 0.0–22.2 |
6 (100.0) 58.9–100.0 |
0 (0.0) 0.0–41.1 |
0 (0.0) 0.0–41.1 |
31 (96.9) 83.4–99.8 |
1 (3.1) 0.17–16.6 |
0 (0.0) 0.0–10.5 |
| Chloramphenicol |
9 (81.8) 50.0–96.7 |
1 (9.1) 0.47–40.4 |
1 (9.1) 0.47–40.4 |
15 (100.0) 77.8–100.0 |
0 (0.0) 0.0–22.2 |
0 (0.0) 0.0–22.2 |
6 (100.0) 58.9–100.0 |
0 (0.0) 0.0–41.1 |
0 (0.0) 0.0–41.1 |
30 (93.8) 80.0–98.9 |
1 (3.1) 0.17–16.6 |
1 (3.1) 0.17–16.6 |
| Ciprofloxacin |
11 (100.0) 73.6–100.0 |
0 (0.0) 0.0–26.5 |
0 (0.0) 0.0–26.5 |
15 (100.0) 77.8–100.0 |
0 (0.0) 0.0–22.2 |
0 (0.0) 0.0–22.2 |
5 (83.3) 41.1–99.1 |
1 (16.7) 0.86–58.9 |
0 (0.0) 0.0–41.1 |
31 (96.9) 83.4–99.8 |
1 (3.1) 0.17–16.6 |
0 (0.0) 0.0–10.5 |
| Gentamicin |
11 (100.0) 73.6–100.0 |
0 (0.0) 0.0–26.5 |
0 (0.0) 0.0–26.5 |
15 (100.0) 77.8–100.0 |
0 (0.0) 0.0–22.2 |
0 (0.0) 0.0–22.2 |
6 (100.0) 58.9–100.0 |
0 (0.0) 0.0–41.1 |
0 (0.0) 0.0–41.1 |
32 (100.0) 89.5–100.0 |
0 (0.0) 0.0–10.5 |
0 (0.0) 0.0–10.5 |
| Kanamycin |
2 (18.2) 33.4–50.0 |
9 (81.8) 50.0–96.7 |
0 (0.0) 0.0–26.5 |
3 (20.0) 5.7–46.6 |
12 (80.0) 53.4–94.3 |
0 (0.0) 0.0–22.2 |
0 (0.0) 0.0–41.1 |
5 (83.3) 41.1–99.1 |
1 (16.7) 0.86–58.9 |
5 (15.6) 6.4–32.6 |
26 (81.3) 64.2–91.5 |
1 (3.1) 0.17–16.6 |
| Meropenem |
11 (100.0) 73.6–100.0 |
0 (0.0) 0.0–26.5 |
0 (0.0) 0.0–26.5 |
15 (100.0) 77.8–100.0 |
0 (0.0) 0.0–22.2 |
0 (0.0) 0.0–22.2 |
6 (100.0) 58.9–100.0 |
0 (0.0) 0.0–41.1 |
0 (0.0) 0.0–41.1 |
32 (100.0) 89.5–100.0 |
0 (0.0) 0.0–10.5 |
0 (0.0) 0.0–10.5 |
| Nalidixic acid |
10 (90.9) 59.6–99.5 |
1 (9.1) 0.47–40.4 |
0 (0.0) 0.0–26.5 |
14 (93.3) 69.8–99.6 |
1 (6.7) 0.35–30.2 |
0 (0.0) 0.0–22.2 |
5 (83.3) 41.1–99.1 |
1 (16.7) 0.86–58.9 |
0 (0.0) 0.0–41.1 |
29 (90.6) 75.3–97.4 |
3 (9.4) 2.6–24.7 |
0 (0.0) 0.0–10.5 |
| Tetracycline |
10 (90.9) 59.6–99.5 |
0 (0.0) 0.0–26.5 |
1 (9.1) 0.47–40.4 |
12 (80.0) 53.4–94.3 |
1 (6.7) 0.35–30.2 |
2 (13.3) 2.4–39.7 |
6 (100.0) 58.9–100.0 |
0 (0.0) 0.0–41.1 |
0 (0.0) 0.0–41.1 |
28 (87.5) 71.9–95.6 |
1 (3.1) 0.17–16.6 |
3 (9.4) 2.6–24.7 |
| Trimethoprim‐sulphamethoxazole |
11 (100.0) 73.6–100.0 |
0 (0.0) 0.0–26.5 |
0 (0.0) 0.0–26.5 |
15 (100.0) 77.8–100.0 |
0 (0.0) 0.0–22.2 |
0 (0.0) 0.0–22.2 |
6 (100.0) 58.9–100.0 |
0 (0.0) 0.0–41.1 |
0 (0.0) 0.0–41.1 |
32 (100.0) 89.5–100.0 |
0 (0.0) 0.0–10.5 |
0 (0.0) 0.0–10.5 |